TSS
GRI

Two Sigma Securities’s GRI Bio GRI Stock Holding History

Two Sigma Securities’s Portfolio GRI Stock Details GRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-33
Closed -$13.1K – 1740
2024
Q4 		$13.1K Buy
+33
New +$11.3K ﹤0.01% 1394
2024
Q2 		– Sell
-2
Closed -$9.65K – 3239
2024
Q1 		$9.65K Buy
+2
New +$17.1K ﹤0.01% 2769
2023
Q2 		– Hold
0
– -$8.21K – 2997
2023
Q1 		– Hold
0
– – – 2482
2022
Q4 		– Hold
0
– – – 2349

Other funds holding GRI

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Two Sigma Securities's GRI Position: Q1 2025 in Review

Two Sigma Securities sold out of GRI Bio (GRI) in Q1 2025, closing a stake of 33 shares — an estimated $13.1K sold.

Two Sigma Securities first reported a position in GRI in Q1 2024 and held it in 2 quarters. The position peaked at $13.1K in Q4 2024. 4 funds tracked by Wall St. Rank hold GRI as of Q1 2025.

  • Two Sigma Securities reported no remaining GRI Bio position as of Q1 2025 after selling out during the quarter.
  • Two Sigma Securities sold 33 GRI Bio shares in Q1 2025, an estimated $13.1K.
  • Two Sigma Securities first reported a position in GRI Bio in Q1 2024 and held it in 2 quarters.
  • Two Sigma Securities's GRI Bio position peaked at $13.1K in Q4 2024.
  • 4 funds tracked by Wall St. Rank held GRI Bio as of Q1 2025.

Based on Two Sigma Securities's 13F filing for Q1 2025, filed 15 May 2025.